Filter
187
Text search:
monoclonal
antibodies
Featured
Recommendations
30
New Publications
32
Language
Document type
No document type
70
Guidelines
49
Studies & Reports
29
Manuals
17
Fact sheets
8
Strategic & Response Plan
5
Training Material
3
Resource Platforms
3
Situation Updates
2
Infographics
1
Countries / Regions
Global
17
India
14
South Africa
6
Germany
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
Philippines
3
Syria
3
Venezuela
3
Mali
2
Niger
2
Pakistan
2
Afghanistan
2
West and Central Africa
2
Middle East and North Africa
2
Africa
2
Russia
2
France
2
Spain
2
Burkina Faso
1
Sierra Leone
1
Liberia
1
Nigeria
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Ethiopia
1
Cameroon
1
Uganda
1
Haiti
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Chad
1
Tanzania
1
Rwanda
1
Mauritania
1
Sudan
1
Benin
1
Argentina
1
Dominican Republic
1
Namibia
1
Peru
1
Brazil
1
North Macedonia
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Western and Central Europe
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
41
Clinical Guidelines
31
Public Health
14
Pharmacy & Technologies
9
Women & Child Health
6
Capacity Building
2
Key Resources
2
Toolboxes
COVID-19
53
NTDs
13
Ebola & Marburg
12
HIV
10
NCDs
9
Malaria
9
Rapid Response
8
Polio
6
Pharmacy
5
Health Financing Toolbox
5
AMR
4
Cholera
3
Zika
3
Planetary Health
3
2.0 Rapid Response
3
Mental Health
2
Conflict
1
Natural Hazards
1
Refugee
1
This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of tests used in combination to improve the accuracy of
...
Enfrentando la enfermedad de Alzheimer en los países en desarrollo.
Rev Neuropsiquiatr 80 (2), 2017 (P. 105-110)
Recibido: 03/02/2017 Aceptado: 12/06/2017
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
Product:BDFACSCountTM InstrumentSystemwithFACSCountTM ControlKitandBD FACSCountTM CD4ReagentKit(AbsoluteandPercentageCD4+Counts)
Number: PQDx 0133-045-00
0133-045-00 WHO
PQDx PR
June/2016, version 2.0
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators
...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE
...
Временные рекомендации
9 августа 2021 г.
Цель данного документа - описать минимальный набор мероприятий по эпиднадзору, рекомендуемых на национальном уровне для вы
...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunac
...
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,
...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali
...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R
...
